Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation

Oncogene

Volumn 25, Issue 16, 2006, Pages 2379-2392

  Munoz Najar U M ^a   Neurath, K M ^a   Vumbaca, F ^a   Claffey, K P ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Breast cancer; Hypoxia; Invasion; MT1 MMP; RhoA

Indexed keywords

GELATINASE A; GUANOSINE TRIPHOSPHATASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADENOVIRUS; ADULT; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER INVASION; CLINICAL ARTICLE; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; INTRADUCTAL CARCINOMA; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; ENZYME ACTIVATION; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; NEOPLASM INVASIVENESS; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

ADENOVIRIDAE;

EID: 33646153307     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209273     Document Type: Article

References (75)

1. Annabi B, Lee YT, Turcotte S, Naud E, Desrosiers RR, Champagne M et al. (2003). Stem Cells 21: 337-347.
2. Azzam HS, Arand G, Lippman ME, Thompson EW. (1993). J Natl Cancer Inst 85: 1758-1764.
3. Bailly K, Ridley AJ, Hall SM, Haworth SG, Wieczorek SJ, Wu AH et al. (2004). Circ Res 94: 1383-1391.
4. Bartolome RA, Galvez BG, Longo N, Baleux F, Van Muijen GN, Sanchez-Mateos P et al. (2004). Cancer Res 64: 2534-2543.
5. Ben-Yosef Y, Lahat N, Shapiro S, Bitterman H, Miller A. (2002). Circ Res 90: 784-791.
6. Brat DJ, Castellano-Sanchez AA, Hunter SB, Pecot M, Cohen C, Hammond EH et al. (2004). Cancer Res 64: 920-927.
7. Brinckerhoff CE, Matrisian LM. (2002). Nat Rev Mol Cell Biol 3: 207-214.
8. Burke B, Giannoudis A, Corke KP, Gill D, Wells M, Ziegler-Heitbrock L et al. (2003). Am J Pathol 163: 1233-1243.
9. Canning MT, Postovit LM, Clarke SH, Graham CH. (2001). Exp Cell Res 267: 88-94.
10. Cao J, Sato H, Takino T, Seiki M. (1995). J Biol Chem 270: 801-805.
11. Chang C, Werb Z. (2001). Trends Cell Biol 11: S37-S43.
12. Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo KT, Manseau EJ et al. (1996). Cancer Res 56: 172-181.
13. DeClerck YA, Mercurio AM, Stack MS, Chapman HA, Zutter MM, Muschel RJ et al. (2004). Am J Pathol 164: 1131-1139.
14. Deschamps AM, Yarbrough WM, Squires CE, Allen RA, McClister DM, Dowdy KB et al. (2005). Circulation 111: 1166-1174.
15. d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J et al. (1997). Eur J Biochem 250: 751-757.
16. Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N. (2000). Breast Cancer Res 2: 252-257.
17. Edwards DR, Murphy G. (1998). Nature 394: 527-528.
18. Egeblad M, Werb Z. (2002). Nat Rev Cancer 2: 161-174.
19. Fahling M, Perlewitz A, Doller A, Thiele BJ. (2004). Comp Biochem Physiol C Toxicol Pharmacol 139: 119-126.
20. Freije JM, Balbin M, Pendas AM, Sanchez LM, Puente XS, Lopez-Otin C. (2003). Adv Exp Med Biol 532: 91-107.
21. Fritz G, Just I, Kaina B. (1999). Int J Cancer 81: 682-687.
22. Giannelli G, Bergamini C, Marinosci F, Fransvea E, Quaranta M, Lupo L et al. (2002). Int J Cancer 97: 425-431.
23. Graham CH, Forsdike J, Fitzgerald CJ, Macdonald-Goodfellow S. (1999). Int J Cancer 80: 617-623.
24. Hewitt R, Dano K. (1996). Enzyme Protein 49: 163-173.
25. Hofmann UB, Eggert AA, Blass K, Brocker EB, Becker JC. (2005). Arch Dermatol Res 4: 1-7.
26. Ishigaki S, Toi M, Ueno T, Matsumoto H, Muta M, Koike M et al. (1999). Jpn J Cancer Res 90: 516-522.
27. Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N et al. (2001). EMBO J 20: 4782-4793.
28. Jiang A, Lehti K, Wang X, Weiss SJ, Keski-Oja J, Pei D. (2001). Proc Natl Acad Sci USA 98: 13693-13698.
29. Jones JL, Glynn P, Walker RA. (1999). J Pathol 189: 161-168.
30. Kalman D, Gomperts SN, Hardy S, Kitamura M, Bishop JM. (1999). Mol Biol Cell 10: 1665-1683.
31. Kinoshita T, Sato H, Takino T, Itoh M, Akizawa T, Seiki M. (1996). Cancer Res 56: 2535-2538.
32. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G et al. (2003). Cancer Res 63: 1138-1143.
33. Lambert E, Dasse E, Haye B, Petitfrere E. (2004). Crit Rev Oncol Hematol 49: 187-198.
34. Lehti K, Lohi J, Valtanen H, Keski-Oja J. (1998). Biochem J 334(Pt 2): 345-353.
35. Leufgen H, Bihl MP, Rudiger JJ, Gambazzi J, Perruchoud AP, Tamm M et al. (2005). J Cell Physiol 204: 146-154.
36. Liu W, Saint DA. (2002). Biochem Biophys Res Commun 294: 347-353.
37. Lolmede K, Durand de Saint Front V, Galitzky J, Lafontan M, Bouloumie A. (2003). Int J Obes Relat Metab Disord 27: 1187-1195.
38. Mimori K, Ueo H, Shirasaka C, Mori M. (2001). Oncol Rep 8: 401-403.
39. Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H et al. (2002). EMBO J 21: 3949-3959.
40. Nagase H, Woessner Jr JF. (1999). J Biol Chem 274: 21491-21494.
41. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. (2000). J Clin Oncol 18: 1135-1149.
42. Nelson WJ. (2003). Nature 422: 766-774.
43. Ottino P, Finley J, Rojo E, Ottlecz A, Lambrou GN, Bazan HE et al. (2004). Mol Vis 10: 341-350.
44. Oxford G, Theodorescu D. (2003). Cancer Lett 189: 117-128.
45. Paik JH, Chae S, Lee MJ, Thangada S, Hla T. (2001). J Biol Chem 276: 11830-11837.
46. Petrella BL, Lohi J, Brinckerhoff CE. (2005). Oncogene 24: 1043-1052.
47. Remacle A, Murphy G, Roghi C. (2003). J Cell Sci 116: 3905-3916.
48. Ridgway PF, Ziprin P, Alkhamesi N, Paraskeva PA, Peck DH, Darzi AW. (2005). J Surg Res 124: 180-186.
49. Rozanov DV, Deryugina EI, Monosov EZ, Marchenko ND, Strongin AY. (2004). Exp Cell Res 293: 81-95.
50. Saad S, Gottlieb DJ, Bradstock KF, Overall CM, Bendall LJ. (2002). Cancer Res 62: 283-289.
51. Sameshima T, Nabeshima K, Toole BP, Yokogami K, Okada Y, Goya T et al. (2000). Cancer Lett 157: 177-184.
52. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E et al. (1994). Nature 370: 61-65.
53. Sato Y. (2003). Endothelium 10: 287-290.
54. Seiki M. (2002). Curr Opin Cell Biol 14: 624-632.
55. Semenza GL. (2002). Trends Mol Med 8: S62-S67.
56. Sloane JP, Ormerod MG. (1981). Cancer 47: 1786-1795.
57. Stetler-Stevenson WG, Yu AE. (2001). Semin Cancer Biol 11: 143-152.
58. Subarsky P, Hill RP. (2003). Clin Exp Metastasis 20: 237-250.
59. Symons M, Rusk N. (2003). Curr Biol 13: R409-R418.
60. Takino T, Miyamori H, Kawaguchi N, Uekita T, Seiki M, Sato H. (2003). Biochem Biophys Res Commun 304: 160-166.
61. Turcotte S, Desrosiers RR, Beliveau R. (2003). J Cell Sci 116: 2247-2260.
62. Turcotte S, Desrosiers RR, Beliveau R. (2004). Am J Physiol Renal Physiol 286: F338-F348.
63. Udayakumar TS, Chen ML, Bair EL, Von Bredow DC, Cress AE, Nagle RB et al. (2003). Cancer Res 63: 2292-2299.
64. Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H et al. (1997). Cancer Res 57: 2055-2060.
65. Vaupel P. (2004). Oncologist 9(Suppl 5): 10-17.
66. Wang X, Ma D, Keski-Oja J, Pei D. (2004). J Biol Chem 279: 9331-9336.
67. Wang Z, Juttermann R, Soloway PD. (2000). J Biol Chem 275: 26411-26415.
68. Yamanaka M, Ishikawa O. (2000). J Dermatol Sci 24: 99-104.
69. Yoon SO, Park SJ, Yun CH, Chung AS. (2003). J Biochem Mol Biol 36: 128-137.
70. Yoon SO, Shin S, Mercurio AM. (2005). Cancer Res 65: 2761-2769.
71. Yu M, Bowden ET, Sitlani J, Sato H, Seiki M, Mueller SC et al. (1997). Cancer Res 57: 5028-5032.
72. Zhai Y, Rotary KB, Nan B, Bosch FX, Munoz N, Weiss SJ et al. (2005). Cancer Res 65: 6543-6550.
73. Zucker S, Drews M, Conner C, Foda HD, DeClerck YA, Langley KE et al. (1998). J Biol Chem 273: 1216-1222.
74. Zucker S, Hymowitz M, Conner C, DeClerck Y, Cao J. (2004). Exp Cell Res 293: 164-174.
75. Zucker S, Hymowitz M, Conner C, Diyanni E, Cao J. (2002). Lab Invest 82: 1673-1684.